Phase III study of nolasiban for in-vitro fertilisation
Phase of Trial: Phase III
Latest Information Update: 03 Oct 2018
At a glance
- Drugs Nolasiban (Primary)
- Indications Female infertility
- Focus Therapeutic Use
- Acronyms IMPLANT3
- 03 Oct 2018 According to an ObsEva media release company has received feedback from two European regulatory authorities.Pending positive outcome of an additional Phase 3 trial, both regulatory bodies have agreed to a proposed MAA that will include IMPLANT 1 and IMPLANT 2 trial results, as well as results from the additional Phase 3 clinical trial.MAA submission is anticipated by the end of 2019.
- 08 Aug 2018 According to an ObsEva media release, the company expects to initiate this trial by the end of 2018.
- 25 May 2018 New trial record